Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGDS | O60760 | 10/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | MPO | P05164 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.41 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL721917 | 0.82 | HPGDS (0.55) | HPGDSKDM4EADORA3LRRK2NPC1 | |
| SCHEMBL6237473 | 0.81 | MGAM (0.65) | HPGDSKDM4ECYP1A2CYP3A4NPC1 | |
| SCHEMBL3788261 | 0.80 | MGAM (0.64) | HPGDSKDM4ELRRK2NPC1RAB9A | |
| SCHEMBL28946126 | 0.78 | ALOX15 (0.54) | HPGDSKDM4EALDH1A1 | |
| SCHEMBL7541373 | 0.78 | KDM4E (0.55) | KDM4EMPOCYP1A2CYP3A4ADORA3 | |
| SCHEMBL1519811 | 0.78 | SMYD3 (0.60) | KDM4EMPOCYP1A2CYP3A4ADORA3 | |
| SCHEMBL14067689 | 0.75 | HPGDS (0.44) | HPGDSKDM4ELRRK2ALDH1A1MGAM | |
| SCHEMBL30546532 | 0.75 | MAOB (0.56) | HPGDSCYP2C19NPC1RAB9AALDH1A1 | |
| SCHEMBL1017525 | 0.75 | MAOB (0.56) | HPGDSCYP2C19NPC1RAB9AALDH1A1 | |
| Hydrochloric Acid SCHEMBL20162133 | 0.74 | MAOB (0.55) | HPGDSCYP2C19NPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080242694-A1 | Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith | D SIDOCKY NEIL R | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242694-A1 | Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith | JAK2, CHEK2, MTOR | HPGDS 111/4885KDM4E 1212/4885MPO 476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.